EMS-CHEMIE HOLDING Balance Sheet Health
Financial Health criteria checks 5/6
EMS-CHEMIE HOLDING has a total shareholder equity of CHF2.1B and total debt of CHF14.8M, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are CHF2.5B and CHF375.5M respectively. EMS-CHEMIE HOLDING's EBIT is CHF544.7M making its interest coverage ratio -101.9. It has cash and short-term investments of CHF613.5M.
Key information
0.70%
Debt to equity ratio
CHF 14.78m
Debt
| Interest coverage ratio | -101.9x |
| Cash | CHF 613.49m |
| Equity | CHF 2.10b |
| Total liabilities | CHF 375.50m |
| Total assets | CHF 2.48b |
Recent financial health updates
No updates
Recent updates
Calculating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Aug 05
EMS-CHEMIE HOLDING (VTX:EMSN) Is Increasing Its Dividend To CHF17.25
Jul 15EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Not Quite Adding Up
Jun 24EMS-CHEMIE HOLDING (VTX:EMSN) Has More To Do To Multiply In Value Going Forward
Apr 21EMS-CHEMIE HOLDING AG's (VTX:EMSN) Share Price Could Signal Some Risk
Mar 19Estimating The Fair Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Feb 26EMS-CHEMIE HOLDING (VTX:EMSN) May Have Issues Allocating Its Capital
Dec 19Pinning Down EMS-CHEMIE HOLDING AG's (VTX:EMSN) P/E Is Difficult Right Now
Dec 01Estimating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Nov 13Financial Position Analysis
Short Term Liabilities: EMSN's short term assets (CHF1.7B) exceed its short term liabilities (CHF257.6M).
Long Term Liabilities: EMSN's short term assets (CHF1.7B) exceed its long term liabilities (CHF117.9M).
Debt to Equity History and Analysis
Debt Level: EMSN has more cash than its total debt.
Reducing Debt: EMSN's debt to equity ratio has increased from 0.2% to 0.7% over the past 5 years.
Debt Coverage: EMSN's debt is well covered by operating cash flow (3241%).
Interest Coverage: EMSN earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/08 17:34 |
| End of Day Share Price | 2025/10/08 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EMS-CHEMIE HOLDING AG is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Aron Ceccarelli | Berenberg |